Edward J. Dulac Iii.

Companies

• Intellia TherapeuticsChief financial officer Jul 24, 2024 to now¹
• Fate TherapeuticsChief financial officer Aug 19, 2020 to Mar 5, 2024²

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

• Intellia Therapeutics NTLA148,175 shares³$1.7M at $11.48Jul 22, 2026
• FTFate Therapeutics FATE101,479 shares⁴$190.8K at $1.88Mar 4, 2024

As of each latest filing. The line shows shares held over time.

Recent filings

• Jul 22, 2026Sold 8,111 shares at $11.25 of Intellia Therapeutics³
• Jul 2, 2026Sold 4,677 shares at $18.00 of Intellia Therapeutics⁵
• Mar 1, 2026Granted 61,280 shares of Intellia Therapeutics⁶
• Jan 5, 2026Sold 6,379 shares at $9.21 of Intellia Therapeutics⁷
• Jul 23, 2025Sold 7,462 shares at $14.02 of Intellia Therapeutics⁸
• Mar 1, 2025Granted 47,200 shares of Intellia Therapeutics⁹
• Jul 22, 2024Granted 66,324 shares of Intellia Therapeutics¹⁰
• Mar 4, 2024Sold 2,447 shares at $7.77 of Fate Therapeutics⁴
• Jan 29, 2024Sold 1,849 shares at $5.00 of Fate Therapeutics¹¹
• Jan 9, 2024Sold 7,028 shares at $4.37 of Fate Therapeutics¹²
• Jan 2, 2024Sold 5,182 shares at $3.66 of Fate Therapeutics¹³
• Dec 18, 2023Sold 1,585 shares at $3.50 of Fate Therapeutics¹⁴
• Aug 18, 2023Sold 4,718 shares at $2.80 of Fate Therapeutics¹⁵
• Jul 5, 2023Sold 5,182 shares at $4.83 of Fate Therapeutics¹⁶
• Jan 10, 2023Sold 7,331 shares at $5.24 of Fate Therapeutics¹⁷
• Aug 18, 2022Sold 432 shares at $30.41 of Fate Therapeutics¹⁸
• Aug 18, 2022Sold 4,703 shares at $29.75 of Fate Therapeutics¹⁸
• Jan 25, 2022Granted 33,302 shares of Fate Therapeutics¹⁹
• Jan 11, 2022Sold 390 shares at $49.16 of Fate Therapeutics²⁰
• Jan 11, 2022Sold 1,380 shares at $48.25 of Fate Therapeutics²⁰
• Dec 20, 2021Sold 15,977 shares at $60.00 of Fate Therapeutics²¹
• Dec 20, 2021Exercised options 14,437 shares at $35.52 of Fate Therapeutics²¹
• Nov 19, 2021Granted 59,540 shares of Fate Therapeutics²²